Bitnomial, a Chicago-based derivatives exchange, has announced the launch of the first regulated Aptos futures product in the United States. Initially available to institutional traders, the product will be accessible to retail investors via the Botanical platform in the coming weeks. The futures contracts will have monthly expirations and can be settled in either USD or APT, depending on the position direction. Traders can use cryptocurrency or USD as margin through Bitnomial's clearinghouse. The company also plans to introduce APT perpetual contracts and options in the future.